News

H-E-B joins a lawsuit with Kroger, Albertsons and Walgreens to sue a pharmaceutical company for conspiring to delay the ...
Defendants Takeda Pharmaceutical Co. Ltd. and TWi Pharmaceuticals Inc. allegedly engaged in a reverse payment deal in which TWi agreed to refrain from launching a generic version of Takeda’s Dexilant ...
A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.
Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an FDA-approved PD-L1 inhibitor. Japan's Ono Pharmaceutical bought an antisense ...
Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company ...
Sarah Kellam is a Kentucky native and played collegiate golf at Northern Kentucky University. She currently serves as a Manager of Digital Content and prior to the LPGA, Sarah worked as a ...
Japanese rookie Rio Takeda equalled the course record on her way to a dominant victory at the Blue Bay LPGA in China on Sunday. Takeda shot a blistering bogey-free round of 64, which included eight ...
SANYA, China — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA’s Blue Bay tournament by six shots ahead of Minjee Lee of Australia, the second LPGA title for the young Japanese. The ...
SANYA, China — Rio Takeda of Japan shot a 3-under 69 on Saturday to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s southern island of Hainan.